Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

<br />Toni Choureiri, MD, discusses the biomarker analyses from JAVELIN Renal 101.<br /><br />Background: The phase 3 JAVELIN Renal 101 trial in previously untreated patients (pts) with aRCC demonstrated a progre... Author: Annual-Meeting Added: 06/06/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts